Public Health England is responsible for the NHS Screening Programmes
Quality Assurance (London)
Antenatal Updates
Michelle Onslow, Senior QA Advisor
Sickle Cell and Thalassaemia
• Review of failsafe processes the Map of Medicine
pathways – mapping incidents against the pathway
• Reviewing of UK NSC publications, educational resources
and NHS Choices
• Looking at the main reasons why women present late for
booking – aiming to focus resources in key areas
• IVF/Fertility – screening often undertaken if donor eggs
used but not if using their own, National programme doing
communication on this in conjunction with voluntary
agencies
• 2016/17 service specification to be released soon
2 Presentation title - edit in Header and Footer
Sickle Cell and Thalassaemia
• Courses at KCL – funded places
being offered:
Short counselling course – for non
specialists, 19th November and 21st
April 2016 both in London.
Genetic risk assessment and
counselling module, four day course for
staff delivering counselling 12th/13th
May 2016 and 16th/17th June 2016
Email sent out yesterday with
instructions
http://cpd.screening.nhs.uk/sct-
externaltraining
3 Presentation title - edit in Header and Footer
Sickle Cell and Thalassaemia
• SC&T e-learning resource:
Target audience, midwives, health visitors, GP’s and
counsellors
Nine modules that follow the screening pathway
Films on completing the FOQ, partner testing and
giving positive results
Information on sickle cell complications, thalassaemia
complications and a world map of prevalence
Tips on talking to parents, links to key resources and
quiz/test and certificate
Coming soon: http://cpd.screening.nhs.uk/
4 Presentation title - edit in Header and Footer
Sickle Cell and Thalassaemia
• PND Outcome forms:
 Short term: Decision following PND
 Long term: Pregnancy outcome, delivery etc.
 Completion and return of the forms is low
 Lack of evidence at National level to inform
standards, KPI’s etc.
 We will now look for evidence that these are
completed and returned as part of a QA visit
 Included as part of policy, evidence of a process in
place for completion and return of the forms
5 Presentation title - edit in Header and Footer
FASP
• New Standards:
 Nine new standards
 Some data required from local providers, some
collected nationally, most already collected via KPI’s
annual reports etc.
 National submission template with instructions
coming soon
6 Presentation title - edit in Header and Footer
FASP
• T13/18:
 Written consent not required but there must be clear
documentation of the offer + acceptance/decline of
T21 and T13/18
 Request form needs to have an option to accept or
decline T21 and T13/18 separately
 Report must have two risks one for T21 and one for
T13/18
 Parents must be aware that PND would identify a
result for all three conditions regardless of risk results
 Most Trusts directly contract the lab – you can
influence change
7 Presentation title - edit in Header and Footer
FASP
• KPI FA2 Pilot:
 Overall positive feedback from the units that took part
– many continuing to submit
 Some challenges identified – IT, correct identification
of the cohort
 A number of women were identified as missed
 Failsafe’s not in place
 Recommending that it is introduced as a KPI
 Awaiting a National decision – will provide more detail
as soon as we know
8 Presentation title - edit in Header and Footer
Infectious Diseases
• New standards, 2016/17 service specification, laboratory
and operational handbooks
• Regional roll out workshops Jan-March 2016
• Cessation of Rubella: No decision made yet, awaiting
ministerial sign off, we will update you as soon as we
know
• New e-learning resource coming next year
• New Hep B and HIV leaflets, leaflets translated into 20
different languages, available to download
9 Presentation title - edit in Header and Footer
Infectious Diseases
• Professional forum, midwives, nurse specialists, self
nominated members, helping to produce educational
resources
• Women who decline:
 Evidence to show they have a higher prevalence of
HIV
 Need a robust pathway for re-offer
 Should see screening team or specialist
• ‘Late Booking’ will become 20 weeks gestation – due to
commencement of antiretroviral therapy
• Request form needs to include acceptance and decline
for each condition
10 Presentation title - edit in Header and Footer
Infectious Diseases
• Results should be given by an appropriately trained
clinician (including Hep B)
• New KPI’s for coverage for Hep B & Syphilis
• ID2: being reviewed based on findings from national
audit
• Looking at all data collected:
 streamlining to reduce duplication of requests
 ensure consistency
 simplify the process
 Online data reporting system
11 Presentation title - edit in Header and Footer
General
• Screening Blog: https://phescreening.blog.gov.uk
 All up to date information re: screening
 Sign up to receive updates
 Email cascades will stop so if you are not signed up
you won’t know!
 If you would like to do a blog contact us
• London QA Service have a new email address:
 PHE.LondonQA@nhs.net
 The old address (PHE.screeningqalondon@nhs.net)
will be deactivated on 01.11.15
12 Presentation title - edit in Header and Footer
General
• Annual reports 2014/15:
 QA Team will not be doing individual feedback reports
 General London wide presentation at the next forum
 Local feedback at your TSSG
 Template will be reviewed nationally once new
standards are published to reduce duplication etc.
• NMC Revalidation:
 Remind staff looking for CPD evidence of the free
NSC e-learning resources
13 Presentation title - edit in Header and Footer

1 antenatal updates Michelle Onslow

  • 1.
    Public Health Englandis responsible for the NHS Screening Programmes Quality Assurance (London) Antenatal Updates Michelle Onslow, Senior QA Advisor
  • 2.
    Sickle Cell andThalassaemia • Review of failsafe processes the Map of Medicine pathways – mapping incidents against the pathway • Reviewing of UK NSC publications, educational resources and NHS Choices • Looking at the main reasons why women present late for booking – aiming to focus resources in key areas • IVF/Fertility – screening often undertaken if donor eggs used but not if using their own, National programme doing communication on this in conjunction with voluntary agencies • 2016/17 service specification to be released soon 2 Presentation title - edit in Header and Footer
  • 3.
    Sickle Cell andThalassaemia • Courses at KCL – funded places being offered: Short counselling course – for non specialists, 19th November and 21st April 2016 both in London. Genetic risk assessment and counselling module, four day course for staff delivering counselling 12th/13th May 2016 and 16th/17th June 2016 Email sent out yesterday with instructions http://cpd.screening.nhs.uk/sct- externaltraining 3 Presentation title - edit in Header and Footer
  • 4.
    Sickle Cell andThalassaemia • SC&T e-learning resource: Target audience, midwives, health visitors, GP’s and counsellors Nine modules that follow the screening pathway Films on completing the FOQ, partner testing and giving positive results Information on sickle cell complications, thalassaemia complications and a world map of prevalence Tips on talking to parents, links to key resources and quiz/test and certificate Coming soon: http://cpd.screening.nhs.uk/ 4 Presentation title - edit in Header and Footer
  • 5.
    Sickle Cell andThalassaemia • PND Outcome forms:  Short term: Decision following PND  Long term: Pregnancy outcome, delivery etc.  Completion and return of the forms is low  Lack of evidence at National level to inform standards, KPI’s etc.  We will now look for evidence that these are completed and returned as part of a QA visit  Included as part of policy, evidence of a process in place for completion and return of the forms 5 Presentation title - edit in Header and Footer
  • 6.
    FASP • New Standards: Nine new standards  Some data required from local providers, some collected nationally, most already collected via KPI’s annual reports etc.  National submission template with instructions coming soon 6 Presentation title - edit in Header and Footer
  • 7.
    FASP • T13/18:  Writtenconsent not required but there must be clear documentation of the offer + acceptance/decline of T21 and T13/18  Request form needs to have an option to accept or decline T21 and T13/18 separately  Report must have two risks one for T21 and one for T13/18  Parents must be aware that PND would identify a result for all three conditions regardless of risk results  Most Trusts directly contract the lab – you can influence change 7 Presentation title - edit in Header and Footer
  • 8.
    FASP • KPI FA2Pilot:  Overall positive feedback from the units that took part – many continuing to submit  Some challenges identified – IT, correct identification of the cohort  A number of women were identified as missed  Failsafe’s not in place  Recommending that it is introduced as a KPI  Awaiting a National decision – will provide more detail as soon as we know 8 Presentation title - edit in Header and Footer
  • 9.
    Infectious Diseases • Newstandards, 2016/17 service specification, laboratory and operational handbooks • Regional roll out workshops Jan-March 2016 • Cessation of Rubella: No decision made yet, awaiting ministerial sign off, we will update you as soon as we know • New e-learning resource coming next year • New Hep B and HIV leaflets, leaflets translated into 20 different languages, available to download 9 Presentation title - edit in Header and Footer
  • 10.
    Infectious Diseases • Professionalforum, midwives, nurse specialists, self nominated members, helping to produce educational resources • Women who decline:  Evidence to show they have a higher prevalence of HIV  Need a robust pathway for re-offer  Should see screening team or specialist • ‘Late Booking’ will become 20 weeks gestation – due to commencement of antiretroviral therapy • Request form needs to include acceptance and decline for each condition 10 Presentation title - edit in Header and Footer
  • 11.
    Infectious Diseases • Resultsshould be given by an appropriately trained clinician (including Hep B) • New KPI’s for coverage for Hep B & Syphilis • ID2: being reviewed based on findings from national audit • Looking at all data collected:  streamlining to reduce duplication of requests  ensure consistency  simplify the process  Online data reporting system 11 Presentation title - edit in Header and Footer
  • 12.
    General • Screening Blog:https://phescreening.blog.gov.uk  All up to date information re: screening  Sign up to receive updates  Email cascades will stop so if you are not signed up you won’t know!  If you would like to do a blog contact us • London QA Service have a new email address:  PHE.LondonQA@nhs.net  The old address (PHE.screeningqalondon@nhs.net) will be deactivated on 01.11.15 12 Presentation title - edit in Header and Footer
  • 13.
    General • Annual reports2014/15:  QA Team will not be doing individual feedback reports  General London wide presentation at the next forum  Local feedback at your TSSG  Template will be reviewed nationally once new standards are published to reduce duplication etc. • NMC Revalidation:  Remind staff looking for CPD evidence of the free NSC e-learning resources 13 Presentation title - edit in Header and Footer